Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
35,033
archived clinical trials in
Lung Cancer

Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
A Phase I/II Study of Active Immunotherapy With Ad5[E1-,E2b-]-CEA Vaccine in Patients With Advanced or Metastatic Malignancies Expressing CEA
Status: Enrolling
Updated:  3/21/2013
Duke Cancer Research Institute, Duke University
mi
from
Durham, NC
Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
A Phase I/II Study of Active Immunotherapy With Ad5[E1-,E2b-]-CEA Vaccine in Patients With Advanced or Metastatic Malignancies Expressing CEA
Status: Enrolling
Updated: 3/21/2013
Duke Cancer Research Institute, Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
A Phase I/II Study of Active Immunotherapy With Ad5[E1-,E2b-]-CEA Vaccine in Patients With Advanced or Metastatic Malignancies Expressing CEA
Status: Enrolling
Updated:  3/21/2013
Medical Oncology Associates PS
mi
from
Spokane, WA
Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
A Phase I/II Study of Active Immunotherapy With Ad5[E1-,E2b-]-CEA Vaccine in Patients With Advanced or Metastatic Malignancies Expressing CEA
Status: Enrolling
Updated: 3/21/2013
Medical Oncology Associates PS
mi
from
Spokane, WA
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
Community Regional Medical Center
mi
from
Fresno, CA
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
Community Regional Medical Center
mi
from
Fresno, CA
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
Penrose Cancer Center
mi
from
Colorado Springs, CO
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
Penrose Cancer Center
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
Jupiter Medical Center
mi
from
Jupiter, FL
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
Jupiter Medical Center
mi
from
Jupiter, FL
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
Advocate Christ Medical Center
mi
from
Oak Lawn, IL
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
Advocate Christ Medical Center
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
Parkview Cancer Center
mi
from
Fort Wayne, IN
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
Parkview Cancer Center
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
Central Baptist Hospital
mi
from
Lexington, KY
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
Central Baptist Hospital
mi
from
Lexington, KY
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
St. Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
St. Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
St. Mary's of Michigan
mi
from
Saginaw, MI
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
St. Mary's of Michigan
mi
from
Saginaw, MI
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
St. Mary's Duluth Clinic Health System
mi
from
Duluth, MN
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
St. Mary's Duluth Clinic Health System
mi
from
Duluth, MN
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
St. Mary's
mi
from
Reno, NV
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
St. Mary's
mi
from
Reno, NV
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
St. Luke's Episcopal Hospital
mi
from
Houston, TX
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
St. Luke's Episcopal Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
Denver CyberKnife
mi
from
Lone Tree, CO
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
Denver CyberKnife
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
Saint Louis University
mi
from
Saint Louis, MO
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
Saint Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
UT MD Anderson Cancer Center
mi
from
Houston, TX
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated:  4/5/2013
Ruikang Hospital
mi
from
Nanning,
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
International Randomized Study to Compare CyberKnife® Stereotactic Radiotherapy With Surgical Resection in Stage I Non-small Cell Lung Cancer
Status: Enrolling
Updated: 4/5/2013
Ruikang Hospital
mi
from
Nanning,
Click here to add this to my saved trials
A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation
A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation
Status: Enrolling
Updated:  4/8/2013
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation
A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation
Status: Enrolling
Updated: 4/8/2013
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Communicating Smoking Risks Through Graphic Warning Labels
Communicating Smoking Risks Through Graphic Warning Labels
Status: Enrolling
Updated:  4/8/2013
Annenberg Public Policy Center
mi
from
Philadelphia, PA
Communicating Smoking Risks Through Graphic Warning Labels
Communicating Smoking Risks Through Graphic Warning Labels
Status: Enrolling
Updated: 4/8/2013
Annenberg Public Policy Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Communicating Smoking Risks Through Graphic Warning Labels
Communicating Smoking Risks Through Graphic Warning Labels
Status: Enrolling
Updated:  4/8/2013
Lazenby Hall, Ohio State University
mi
from
Columbus, OH
Communicating Smoking Risks Through Graphic Warning Labels
Communicating Smoking Risks Through Graphic Warning Labels
Status: Enrolling
Updated: 4/8/2013
Lazenby Hall, Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS)
A Prospective, Double-blind Randomized Phase III Study of 300 mg Versus 150 mg Erlotinib in Current Smokers With Locally Advanced or Metastatic NSCLC in Second-line Setting After Failure on Chemotherapy (CURRENTS)
Status: Enrolling
Updated:  5/7/2013
Clinical Research Facility
mi
from
Omaha, NE
A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS)
A Prospective, Double-blind Randomized Phase III Study of 300 mg Versus 150 mg Erlotinib in Current Smokers With Locally Advanced or Metastatic NSCLC in Second-line Setting After Failure on Chemotherapy (CURRENTS)
Status: Enrolling
Updated: 5/7/2013
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated:  5/15/2013
Clinical Research Facility
mi
from
Muscle Shoals, AL
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated: 5/15/2013
Clinical Research Facility
mi
from
Muscle Shoals, AL
Click here to add this to my saved trials
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated:  5/15/2013
Clinical Research Facility
mi
from
Omaha, NE
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated: 5/15/2013
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated:  5/15/2013
Clinical Research Facility
mi
from
Lebanon, NH
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated: 5/15/2013
Clinical Research Facility
mi
from
Lebanon, NH
Click here to add this to my saved trials
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated:  5/15/2013
Clinical Research Facility
mi
from
Middletown, OH
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated: 5/15/2013
Clinical Research Facility
mi
from
Middletown, OH
Click here to add this to my saved trials
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated:  5/15/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated: 5/15/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated:  5/15/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated: 5/15/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated:  5/15/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Status: Enrolling
Updated: 5/15/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
A Single Arm, Phase 2 Study of Ganetespib in Subjects With Advanced Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC)
Status: Enrolling
Updated:  5/22/2013
Synta Pharmaceuticals Investigative Site
mi
from
Tampa, FL
A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
A Single Arm, Phase 2 Study of Ganetespib in Subjects With Advanced Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC)
Status: Enrolling
Updated: 5/22/2013
Synta Pharmaceuticals Investigative Site
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
A Single Arm, Phase 2 Study of Ganetespib in Subjects With Advanced Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC)
Status: Enrolling
Updated:  5/22/2013
Synta Pharmaceuticals Investigative Site
mi
from
Detroit, MI
A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
A Single Arm, Phase 2 Study of Ganetespib in Subjects With Advanced Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC)
Status: Enrolling
Updated: 5/22/2013
Synta Pharmaceuticals Investigative Site
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
A Single Arm, Phase 2 Study of Ganetespib in Subjects With Advanced Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC)
Status: Enrolling
Updated:  5/22/2013
Synta Pharmaceuticals Investigative Site
mi
from
Cleveland, OH
A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC)
A Single Arm, Phase 2 Study of Ganetespib in Subjects With Advanced Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Gene Rearrangement (ALK-Positive NSCLC)
Status: Enrolling
Updated: 5/22/2013
Synta Pharmaceuticals Investigative Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Birmingham, AL
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Phoenix, AZ
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Santa Clara, CA
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Aurora, CO
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Decatur, GA
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Indianapolis, IN
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Boston, MA
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
St. Joseph, MO
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
New York, NY
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Cleveland, OH
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Portland, OR
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Philadelphia, PA
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Charleston, SC
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Chattanooga, TN
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/23/2013
Clinical Research Facility
mi
from
Dallas, TX
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/23/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated:  6/6/2013
Stanford University Medical Center, Chest Clinic
mi
from
Stanford, CA
Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status: Enrolling
Updated: 6/6/2013
Stanford University Medical Center, Chest Clinic
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors
A Two Part, Phase 1, Multicenter, Open-label Study of DKN-01 Given Intravenously. Part A: A Dose-Escalation Study in Patients With Multiple Myeloma or Advanced Solid Tumors. Part B: An Expansion Cohort in Patients With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  6/17/2013
TGen Clinical Research Services at Scottsdale Healthcare
mi
from
Scottsdale, AZ
A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors
A Two Part, Phase 1, Multicenter, Open-label Study of DKN-01 Given Intravenously. Part A: A Dose-Escalation Study in Patients With Multiple Myeloma or Advanced Solid Tumors. Part B: An Expansion Cohort in Patients With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 6/17/2013
TGen Clinical Research Services at Scottsdale Healthcare
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors
A Two Part, Phase 1, Multicenter, Open-label Study of DKN-01 Given Intravenously. Part A: A Dose-Escalation Study in Patients With Multiple Myeloma or Advanced Solid Tumors. Part B: An Expansion Cohort in Patients With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated:  6/17/2013
New York Oncology Hematology PC
mi
from
Albany, NY
A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors
A Two Part, Phase 1, Multicenter, Open-label Study of DKN-01 Given Intravenously. Part A: A Dose-Escalation Study in Patients With Multiple Myeloma or Advanced Solid Tumors. Part B: An Expansion Cohort in Patients With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling
Updated: 6/17/2013
New York Oncology Hematology PC
mi
from
Albany, NY
Click here to add this to my saved trials